Literature DB >> 33737418

Risk of dispersion or aerosol generation and infection transmission with nasopharyngeal and oropharyngeal swabs for detection of COVID-19: a systematic review.

Arnav Agarwal1,2, Shannon M Fernando3,4, Kimia Honarmand5, Layla Bakaa6, Sonia Brar7, David Granton8, Dipayan Chaudhuri9, Devin Chetan10,11, Malini Hu8, John Basmaji5, Fiona Muttalib12, Bram Rochwerg2,8, Neill K J Adhikari13,14, Francois Lamontagne15,16, Srinivas Murthy17, David S Hui18,19, Charles D Gomersall20, Samira Mubareka21,22, Janet Diaz23,24, Karen Ea Burns14,25,26, Rachel Couban2,27, Per O Vandvik28.   

Abstract

OBJECTIVES: SARS-CoV-2-related disease, referred to as COVID-19, has emerged as a global pandemic since December 2019. While there is growing recognition regarding possible airborne transmission, particularly in the setting of aerosol-generating procedures and treatments, whether nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 generate aerosols remains unclear.
DESIGN: Systematic review. DATA SOURCES: We searched Ovid MEDLINE and EMBASE up to 3 November 2020. We also searched the China National Knowledge Infrastructure, Chinese Medical Journal Network, medRxiv and ClinicalTrials.gov up to 29 March 2020. ELIGIBILITY CRITERIA: All comparative and non-comparative studies that evaluated dispersion or aerosolisation of viable airborne organisms, or transmission of infection associated with nasopharyngeal or oropharyngeal swab testing.
RESULTS: Of 7702 citations, only one study was deemed eligible. Using a dedicated sampling room with negative pressure isolation room, personal protective equipment including N95 or higher masks, strict sterilisation protocols, structured training with standardised collection methods and a structured collection and delivery system, a tertiary care hospital proved a 0% healthcare worker infection rate among eight nurses conducting over 11 000 nasopharyngeal swabs. No studies examining transmissibility with other safety protocols, nor any studies quantifying the risk of aerosol generation with nasopharyngeal or oropharyngeal swabs for detection of SARS-CoV-2, were identified.
CONCLUSIONS: There is limited to no published data regarding aerosol generation and risk of transmission with nasopharyngeal and oropharyngeal swabs for the detection of SARS-CoV-2. Field experiments to quantify this risk are warranted. Vigilance in adhering to current standards for infection control is suggested. © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Entities:  

Keywords:  Diagnostic microbiology; Infection control; Public health

Mesh:

Substances:

Year:  2021        PMID: 33737418      PMCID: PMC7977073          DOI: 10.1136/bmjopen-2020-040616

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   2.692


  13 in total

1.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

2.  The relative efficacy of respirators and room ventilation in preventing occupational tuberculosis.

Authors:  K P Fennelly; E A Nardell
Journal:  Infect Control Hosp Epidemiol       Date:  1998-10       Impact factor: 3.254

Review 3.  Airborne bacteria and viruses.

Authors:  C S Cox
Journal:  Sci Prog       Date:  1989       Impact factor: 2.774

4.  Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis.

Authors:  Guillaume Butler-Laporte; Alexander Lawandi; Ian Schiller; Mandy Yao; Nandini Dendukuri; Emily G McDonald; Todd C Lee
Journal:  JAMA Intern Med       Date:  2021-03-01       Impact factor: 21.873

5.  The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.

Authors:  Julian P T Higgins; Douglas G Altman; Peter C Gøtzsche; Peter Jüni; David Moher; Andrew D Oxman; Jelena Savovic; Kenneth F Schulz; Laura Weeks; Jonathan A C Sterne
Journal:  BMJ       Date:  2011-10-18

6.  ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.

Authors:  Jonathan Ac Sterne; Miguel A Hernán; Barnaby C Reeves; Jelena Savović; Nancy D Berkman; Meera Viswanathan; David Henry; Douglas G Altman; Mohammed T Ansari; Isabelle Boutron; James R Carpenter; An-Wen Chan; Rachel Churchill; Jonathan J Deeks; Asbjørn Hróbjartsson; Jamie Kirkham; Peter Jüni; Yoon K Loke; Theresa D Pigott; Craig R Ramsay; Deborah Regidor; Hannah R Rothstein; Lakhbir Sandhu; Pasqualina L Santaguida; Holger J Schünemann; Beverly Shea; Ian Shrier; Peter Tugwell; Lucy Turner; Jeffrey C Valentine; Hugh Waddington; Elizabeth Waters; George A Wells; Penny F Whiting; Julian Pt Higgins
Journal:  BMJ       Date:  2016-10-12

7.  Persistence of Severe Acute Respiratory Syndrome Coronavirus 2 in Aerosol Suspensions.

Authors:  Alyssa C Fears; William B Klimstra; Paul Duprex; Amy Hartman; Scott C Weaver; Kenneth S Plante; Divya Mirchandani; Jessica Ann Plante; Patricia V Aguilar; Diana Fernández; Aysegul Nalca; Aysegul Totura; David Dyer; Brian Kearney; Matthew Lackemeyer; J Kyle Bohannon; Reed Johnson; Robert F Garry; Doug S Reed; Chad J Roy
Journal:  Emerg Infect Dis       Date:  2020-06-22       Impact factor: 6.883

8.  The Sensitivity and Costs of Testing for SARS-CoV-2 Infection With Saliva Versus Nasopharyngeal Swabs : A Systematic Review and Meta-analysis.

Authors:  Mayara Lisboa Bastos; Sara Perlman-Arrow; Dick Menzies; Jonathon R Campbell
Journal:  Ann Intern Med       Date:  2021-01-12       Impact factor: 25.391

9.  A Novel Coronavirus from Patients with Pneumonia in China, 2019.

Authors:  Na Zhu; Dingyu Zhang; Wenling Wang; Xingwang Li; Bo Yang; Jingdong Song; Xiang Zhao; Baoying Huang; Weifeng Shi; Roujian Lu; Peihua Niu; Faxian Zhan; Xuejun Ma; Dayan Wang; Wenbo Xu; Guizhen Wu; George F Gao; Wenjie Tan
Journal:  N Engl J Med       Date:  2020-01-24       Impact factor: 91.245

10.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

View more
  1 in total

Review 1.  Coronavirus Disease 2019 and Pituitary Apoplexy: A Single-Center Case Series and Review of the Literature.

Authors:  Rafael Martinez-Perez; Michael W Kortz; Benjamin W Carroll; Daniel Duran; James S Neill; Gustavo D Luzardo; Marcus A Zachariah
Journal:  World Neurosurg       Date:  2021-06-12       Impact factor: 2.104

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.